Eric Testori, an individual and on behalf of all others similarly situated v. Nestlé Health Science US Holdings, Inc., a Delaware Corporation; and DOES 1 through 100, inclusive

CourtDistrict Court, E.D. California
DecidedMay 11, 2026
Docket1:25-cv-01318
StatusUnknown

This text of Eric Testori, an individual and on behalf of all others similarly situated v. Nestlé Health Science US Holdings, Inc., a Delaware Corporation; and DOES 1 through 100, inclusive (Eric Testori, an individual and on behalf of all others similarly situated v. Nestlé Health Science US Holdings, Inc., a Delaware Corporation; and DOES 1 through 100, inclusive) is published on Counsel Stack Legal Research, covering District Court, E.D. California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Eric Testori, an individual and on behalf of all others similarly situated v. Nestlé Health Science US Holdings, Inc., a Delaware Corporation; and DOES 1 through 100, inclusive, (E.D. Cal. 2026).

Opinion

1 2 3 4 5 6 UNITED STATES DISTRICT COURT 7 EASTERN DISTRICT OF CALIFORNIA 8 9 ERIC TESTORI, an individual and on Case No. 1:25-cv-01318-JLT-CDB behalf of all others similarly situated, 10 ORDER GRANTING DEFENDANT’S Plaintiff, MOTION TO DISMISS THE FIRST 11 v. AMENDED COMPLAINT 12 NESTLÉ HEALTH SCIENCE US (Doc. 14.) HOLDINGS, INC., a Delaware 13 Corporation; and DOES 1 through 100, inclusive, 14 Defendants. 15 16 Testori filed the instant putative class action against Nestle Health Science. (Docs. 1, 14.) 17 Plaintiff claims that Defendant engaged in misleading or deceptive advertisements in connection 18 with the labeling and sale of the Carnation Breakfast Essentials Nutritional Drink, in violation of 19 various California state law. (See generally Doc. 14.) For the reasons set forth below, the Court 20 GRANTS Defendant’s motions to dismiss. 21 I. INTRODUCTION 22 A. Factual Background 23 Eric Testori is a resident of Bakersfield, California, and Nestle Health Science is a 24 Delaware Corporation. (Doc. 14 at ¶¶ 12–13.) Defendant manufactures, distributes, markets, 25 advertises, and sells the Product at issue in this case—the Carnation Breakfast Essentials 26 Nutritional Drink Classic French Vanilla (“Product”). (Id. at ¶¶ 1, 17.) Plaintiff brings this 27 putative class action against Defendant, alleging that the latter engaged in “unlawful and 28 deceptive practices” by labeling the Product “as a ‘nutritional drink’ and highlight[ing] its 10g of 1 | protein per serving,” while “fail[ing] to disclose with equal prominence that the Product’s first 2 | two ingredients are water and ... 11 grams of sugar per serving.” (/d. at §§ 1, 18.) A picture of 3 | the front label of the Product, which contains the allegedly misleading/deceptive statements, is 4 | included below. 5 i = “ P a : wl hi <3 a 4.) 6 ¢ La) re a | Ges 4» Raa

9] dea Say | a | conic

Ce 13 | | - ESSENTIALS*. al pes NUTRITIONAL DRINK —

| ED Ct 16 Nidal aS? tres Pie 17 ae RST ae ayaa) 18

20 | (Doc. 18-3 at 2.) According to Plaintiff, “Defendant’s failure to disclose the predominance of 21 || sugar, coupled with its prominent protein and ‘nutritional’ claims, deceived and misled 22 || reasonable consumers into believing that the Product is a balanced, healthful source of breakfast 23 | nutrition; when in fact it is a sweetened beverage primarily made of water and sugar. Reasonable 24 | consumers would not expect a product marketed as ‘Breakfast Essentials’ to contain more sugar 25 | than protein and thus Defendant’s omissions and misrepresentations allowed it to charge a price 26 | premium.” (Doc. 14 at § 22.) 27 B. Procedural History 28 Plaintiff filed the instant action on October 6, 2025, and then filed the First Amended

1 Complaint (“FAC”) on December 8, 2025. (Docs. 1, 14.) Plaintiff’s FAC raises the following four 2 causes of action: (1) California Consumer Legal Remedies Act (“CLRA”), (Doc. 14 at ¶¶ 76–83); 3 (2) California false advertising law (“FAL”), (id. at ¶¶ 84–94); (3) common law fraud, deceit, or 4 misrepresentation, (id. at ¶¶ 95–103); (4) California unfair competition law (“UCL”), (id. at 5 ¶¶ 104–17); and (5) unjust enrichment, (id. at ¶¶ 118–22). 6 On December 19, 2025, Defendant filed a motion to dismiss the FAC for failure to state a 7 claim upon which relief can be granted. (Doc. 18.) The matter is fully briefed and ripe for review. 8 (Pl.’s Opp’n, Doc. 21; Def.’s Reply, Doc. 22.) As indicated, (Doc. 23), the Court took the matter 9 under submission without oral argument. 10 II. PRELIMINARY MATTERS 11 A. Judicial Notice 12 The Court may consider a document if “the plaintiff refers extensively to the document or 13 the document forms the basis of the plaintiff's claim.” United States v. Ritchie, 342 F.3d 903, 908 14 (9th Cir. 2003); see also Knievel v. ESPN, 393 F.3d 1068, 1076 (9th Cir. 2005). In addition, the 15 Court may take judicial notice of facts “not subject to reasonable dispute . . . [that] can be 16 accurately and readily determined from sources whose accuracy cannot reasonably be 17 questioned.” Fed. R. Evid. 201(b). “In the context of a motion to dismiss claims based upon 18 allegedly misleading product labels, the Court may take judicial notice of the images depicting 19 the product labels at issue, without having to convert the motion to dismiss into a motion for 20 summary judgment.” Garza v. Spectrum Brands Pet LLC, 760 F. Supp. 3d 1039, 1046 (E.D. Cal. 21 2024). Here, Plaintiff extensively discussed the front label throughout the FAC. (See generally 22 Doc. 14.) The Court therefore takes judicial notice of pictures of the Product’s packaging. 23 B. Legal Standard 24 Pursuant to Rule 12(b)(6) of the Federal Rules of Civil Procedure, a defendant may move 25 to dismiss a claim for “failure to state a claim upon which relief can be granted.” Fed. R. Civ. P. 26 12(b)(6). To survive a motion to dismiss, the complaint “must contain sufficient factual matter, 27 accepted as true, to ‘state a claim to relief that is plausible on its face.’” Ashcroft v. Iqbal, 556 28 U.S. 662, 678 (2009) (quoting Bell Atl. Corp. v. Twombly, 550 U.S. 544, 570 (2007)). This 1 plausibility inquiry is a “context-specific task that requires [this Court] to draw on its judicial 2 experience and common sense,” id. at 679, and “‘draw all reasonable inferences in favor of the 3 nonmoving party[,]’” Boquist v. Courtney, 32 F.4th 764, 773 (9th Cir. 2022) (quoting Retail 4 Prop. Tr. v. United Bhd. of Carpenters & Joiners of Am., 768 F.3d 938, 945 (9th Cir. 2014)). 5 “Conclusory allegations and unreasonable inferences,” however, “do not provide [] a basis” for 6 determining whether a plaintiff has plausibly stated a claim for relief. Coronavirus Reporter v. 7 Apple, Inc., 85 F.4th 948, 954 (9th Cir. 2023) (citation omitted). 8 III. ANALYSIS 9 A. Preemption 10 Before turning to the details of instant action, the Court finds it helpful to provide a 11 summary of the federal regulatory framework: 12 The FDA regulates three types of claims relevant in this case: express nutrient content claims, implied nutrient content claims, and health 13 claims. See Chacanaca v. Quaker Oats, Co., 752 F. Supp. 2d 1111, 1117 (N.D. Cal. 2010) (citing 21 U.S.C. § 343(q), (r) and 21 C.F.R. 14 §§ 101.13, 101.14). 15 An express nutrient claim is a statement about the level or range of the nutrient in the food product, like “low sodium” or “contains 100 16 calories.” See 21 C.F.R. § 101.13(b)(1). Food product labels may include an express nutrient claim provided that it “does not in any 17 way implicitly characterize the level of the nutrient in the food and it is not false or misleading in any respect (e.g., ‘100 calories’ or ‘5 18 grams of fat’), in which case no disclaimer is required.” 21 C.F.R.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
United States v. Guzman-Rivera
68 F.3d 5 (First Circuit, 1995)
Johnson v. Buckley
356 F.3d 1067 (Ninth Circuit, 2004)
Stutman v. Chemical Bank
731 N.E.2d 608 (New York Court of Appeals, 2000)
Chacanaca v. QUAKER OATS COMPANY
752 F. Supp. 2d 1111 (N.D. California, 2010)
Shavonda Hawkins v. the Kroger Co.
906 F.3d 763 (Ninth Circuit, 2018)
Rojas-Lozano v. Google, Inc.
159 F. Supp. 3d 1101 (N.D. California, 2016)
Krommenhock v. Post Foods, LLC
255 F. Supp. 3d 938 (N.D. California, 2017)
Hadley v. Kellogg Sales Co.
273 F. Supp. 3d 1052 (N.D. California, 2017)
Ebner v. Fresh, Inc.
838 F.3d 958 (Ninth Circuit, 2016)
Mantikas ex rel. Situated v. Kellogg Co.
910 F.3d 633 (Second Circuit, 2018)
Sean McGinity v. the Procter & Gamble Company
69 F.4th 1093 (Ninth Circuit, 2023)
Coronavirus Reporter v. Apple, Inc.
85 F.4th 948 (Ninth Circuit, 2023)

Cite This Page — Counsel Stack

Bluebook (online)
Eric Testori, an individual and on behalf of all others similarly situated v. Nestlé Health Science US Holdings, Inc., a Delaware Corporation; and DOES 1 through 100, inclusive, Counsel Stack Legal Research, https://law.counselstack.com/opinion/eric-testori-an-individual-and-on-behalf-of-all-others-similarly-situated-caed-2026.